Tested Applications
| Positive WB detected in | HEK-293 cells, HL-60 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10352-1-AP targets SNRPD1 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0364 Product name: Recombinant human SNRPD1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-119 aa of BC001721 Sequence: MKLVRFLMKLSHETVTIELKNGTQVHGTITGVDVSMNTHLKAVKMTLKNREPVQLETLSIRGNNIRYFILPDSLPLDTLLVDVEPKVKSKKREAVAGRGRGRGRGRGRGRGRGRGGPRR Predict reactive species |
| Full Name | small nuclear ribonucleoprotein D1 polypeptide 16kDa |
| Calculated Molecular Weight | 16 kDa |
| Observed Molecular Weight | 13 kDa |
| GenBank Accession Number | BC001721 |
| Gene Symbol | SNRPD1 |
| Gene ID (NCBI) | 6632 |
| RRID | AB_2193875 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P62314 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Systemic lupus erythematosus is characterized by antibodies to a variety of intracellular self-antigens, such as dsDNA and Sm, and these serve as hallmarks in the diagnosis of systemic autoimmune diseases. SNRPD1 is one Sm components of the small nuclear ribonucleoprotein complexes(snRNPs). It's a charged protein scaffold to promote snRNP assembly or strengthen snRNP-snRNP interactions through nonspecific electrostatic contacts with RNA. This antibody detectes 13-16 kDa (SMD1) and 30 kDa (SMD1/SMD2 dimer form; PMID:15525645).
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for SNRPD1 antibody 10352-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SNRPD1 Polyclonal antibody (Cat# 10352-1-AP) has 6 total citations. These appear in journals including Neuron, Molecular Cell, Pharmacological Research, Cell Chemical Biology, EPMA Journal, and Journal of Proteome Research. The associated research fields span RNA splicing and ALS, epigenetics/PRMT5 activity, antipsychotic-induced cardiotoxicity, tumor heterogeneity and cancer prognosis, B-cell roles in lung adenocarcinoma, and insulin-secreting cell signaling. Applications cited include Western blot and IHC in human and mouse samples.
| Species | Application | Title |
|---|---|---|
Neuron Inhibition of RNA splicing triggers CHMP7 nuclear entry, impacting TDP-43 function and leading to the onset of ALS cellular phenotypes | ||
Pharmacol Res Second-generation antipsychotics induce cardiotoxicity by disrupting spliceosome signaling: Implications from proteomic and transcriptomic analyses. | ||
Cell Chem Biol Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer. | ||
EPMA J Deciphering key roles of B cells in prognostication and tailored therapeutic strategies for lung adenocarcinoma: a multi-omics and machine learning approach towards predictive, preventive, and personalized treatment strategies | ||





